Table 2.
Baseline Participant Characteristics
Baseline Participant Characteristics (N=38) | |
---|---|
Demographics | |
Sex, % Male | 57.9% |
Age | 21.1 (1.7) (range: 18–25) |
Ethnicity, % Hispanic or Latino | 13.2% |
Race | |
% White | 68.4% |
% Black | 13.2% |
% Other | 18.4% |
Highest Level of Education | |
% High school diploma or less | 5.3% |
% Some college/in college currently | 73.7% |
% 4-year college diploma or more | 21.0% |
Intellectual/Academic Functioning | |
Predicted full scale IQ (WTAR) | 106.1 (9.2) |
Grade point average (on a 4.0 scale) | 3.2 (0.5) |
Psychopathology | |
% Lifetime SCID-IV diagnosis (excluding substance use) | 48.6% |
Major Depressive Disorder: | |
% Lifetime | 45.9% |
% Current | 5.4% |
Anxiety disorder (GAD, PTSD, Panic, Phobia) | |
% Lifetime | 21.6% |
% Current | 16.2% |
Bipolar Disorder | |
% Lifetime | 2.7% |
% Current | 2.7% |
Eating Disorder | |
% Lifetime | 2.7% |
% Current | 2.7% |
% ADHD (Self-Report) | 23.7% |
Concomitant Psychotropic Medications | |
% Currently taking any psychotropic medication | 26.3% |
% currently taking antidepressants | 7.9% |
% currently taking anxiolytics | 2.6% |
% currently taking mood stabilizers | 5.3% |
% currently taking stimulants | 10.5% |
Psychiatric Symptoms | |
Childhood ADHD symptoms (max=9)* | |
Inattention | 3.3 (2.8) |
Hyperactivity | 4.2 (2.9) |
Current ADHD symptoms (max=9)* | |
Inattention | 3.6 (2.8) |
Hyperactivity | 3.7 (2.6) |
MASQ | |
General Distress Anxious Symptoms | 21.7 (7.2) |
Anxious Arousal | 25.2 (7.7) |
General Distress Depressive Symptoms | 25.3 (9.9) |
Anhedonic Depression | 57.1 (13.5) |
A score of ≥5 indicates symptoms consistent with ADHD